Christina M. Coughlin - Net Worth and Insider Trading
Christina M. Coughlin Net Worth
The estimated net worth of Christina M. Coughlin is at least $1,083 dollars as of 2024-11-10. Christina M. Coughlin is the Chief Medical Officer of Rubius Therapeutics Inc and owns about 19,000 shares of Rubius Therapeutics Inc (RUBY) stock worth over $1,083. Details can be seen in Christina M. Coughlin's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Christina M. Coughlin has not made any transactions after 2020-04-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Christina M. Coughlin
Christina M. Coughlin Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Christina M. Coughlin owns 1 companies in total, including Rubius Therapeutics Inc (RUBY) .
Click here to see the complete history of Christina M. Coughlin’s form 4 insider trades.
Insider Ownership Summary of Christina M. Coughlin
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RUBY | Rubius Therapeutics Inc | 2020-04-22 | Chief Medical Officer |
Christina M. Coughlin Latest Holdings Summary
Christina M. Coughlin currently owns a total of 1 stock. Christina M. Coughlin owns 19,000 shares of Rubius Therapeutics Inc (RUBY) as of April 22, 2020, with a value of $1,083.
Latest Holdings of Christina M. Coughlin
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RUBY | Rubius Therapeutics Inc | 2020-04-22 | 19,000 | 0.06 | 1,083 |
Holding Weightings of Christina M. Coughlin
Christina M. Coughlin Form 4 Trading Tracker
According to the SEC Form 4 filings, Christina M. Coughlin has made a total of 1 transactions in Rubius Therapeutics Inc (RUBY) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Rubius Therapeutics Inc is the acquisition of 19,000 shares on April 22, 2020, which cost Christina M. Coughlin around $104,880.
Insider Trading History of Christina M. Coughlin
- 1
Christina M. Coughlin Trading Performance
GuruFocus tracks the stock performance after each of Christina M. Coughlin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Christina M. Coughlin is 6.04%. GuruFocus also compares Christina M. Coughlin's trading performance to market benchmark return within the same time period. The performance of stocks bought by Christina M. Coughlin within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Christina M. Coughlin's insider trading performs compared to the benchmark.
Performance of Christina M. Coughlin
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 16.67 | | | | | |
| Relative Return to S&P 500(%) | 11.09 | | | | | |
Christina M. Coughlin Ownership Network
Ownership Network List of Christina M. Coughlin
Ownership Network Relation of Christina M. Coughlin
Christina M. Coughlin Owned Company Details
What does Rubius Therapeutics Inc do?
Who are the key executives at Rubius Therapeutics Inc?
Christina M. Coughlin is the Chief Medical Officer of Rubius Therapeutics Inc. Other key executives at Rubius Therapeutics Inc include CEO and President Dannielle Appelhans , director & Chief Executive Officer Pablo J Cagnoni , and Chief Scientific Officer Laurence A. Turka .
Rubius Therapeutics Inc (RUBY) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Rubius Therapeutics Inc (RUBY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Rubius Therapeutics Inc (RUBY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Rubius Therapeutics Inc (RUBY)'s detailed insider trading history can be found in Insider Trading Tracker table.
Rubius Therapeutics Inc Insider Transactions
Christina M. Coughlin Mailing Address
Above is the net worth, insider trading, and ownership report for Christina M. Coughlin. You might contact Christina M. Coughlin via mailing address: C/o Rubius Therapeutics, Inc., 399 Binney St., Suite 300, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
